ArticleFoot & ankle orthopaedics2025

Evaluating Clinical Outcomes of Recombinant Human Bone Morphogenetic Protein-2 in the Treatment of Subchondral Plate Damage Associated With Ankle Osteochondral Lesions.

David Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.